Colorectal cancer or colon cancer is cancer of the large intestine (colon), which is the final part of the digestive tract. Both colon cancer and rectal cancer can be referred to as colorectal or bow
Read the full-text online article and more details about New Treatments for Colorectal Cancer: Colorectal Cancer-Cancer of the Colon or Rectum-Is the Second Leading Cause of Cancer-Related Deaths, Behind Lung Cancer, in the United States.
Dasari NA, et al. LBA25 – FRESCO-2: A global phase 3 multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer. Ann Oncol. 2022 Sep;33(suppl_7): S808-S869. Doi:10...
This review will focus on the current immunotherapeutic approaches being developed and will discuss clinical data for some of these new treatments.RafaelCubasMinLiChangyiChen&QizhiYaoInformaworldCancer Biology & TherapyCubas R, Li M, Chen C, Yao Q. Colorectal Cancer: New Advances in Immunotherapy. ...
Treatment of advanced colorectal cancer (CRC) increasingly requires a multidisciplinary approach and multiple treatment options add to the complexity of cl... I Chau,D Cunningham - 《British Journal of Cancer》 被引量: 361发表: 0年 Epidermal growth factor receptor inhibitors in colorectal cancer tre...
This review will focus on the current immunotherapeutic approaches being developed and will discuss clinical data for some of these new treatments. 展开 关键词: colorectal cancer passive immunotherapy active immunotherapy antibodies vaccines DOI: 10.4161/cbt.6.1.3672 被引量: 25 ...
Colorectal cancer is also the most common type of cancer in Japan, with 147,000 new cases diagnosed in 2020. All of these data highlight the need for effective new treatments. “Patients with metastatic disease are often fragile and fatigued—due to both their condition as well as the ...
Background: How to reduce the high incidence rate and mortality of colorectal cancer (CRC) effectively is the focus of current research. Endoscopic treatment of early-stage CRC and colorectal adenomas (CAC) has a high success rate, but although several treatments are available for advanced CRC, ...
manifestation [102]; many patients with low-risk prostate cancer lead a normal life for about 10 years without any treatment: “some prostate cancers might never have developed into serious disease… surgery or radiation therapy may not outweigh the substantial side effects of these treatments...
The applications of thisnuclear medicinetreatmentprotocol could extend to other cancers as well. Larson and Cheal state, "If clinically successful, our approach will expand the repertoire of effective treatments for oncologic patients. The system is designed as a 'plug and play' system, which allows...